Document is current
Any future updates will be listed below
-
Authors
Reyes, Nikolai Gil D. https://orcid.org/0000-0001-8762-6556
Bendahan, Nathaniel https://orcid.org/0000-0003-2167-5667
Swinkin, Emily https://orcid.org/0000-0002-5208-7203
Lang, Anthony E. https://orcid.org/0000-0003-1229-3667
Bassett, Anne S. https://orcid.org/0000-0002-0681-7279
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 12 July 2024
First Online: 18 July 2024
Declarations
:
: This report conforms to the Declaration of Helsinki. The authors confirm that research ethics board approval was not required for this study. Verbal and written informed consent were obtained from patients and their caregivers. Consent was obtained to publish the videotaped examination only for Case 1.
: Dr. Lang has served as an advisor for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB; received honoraria from Sun Pharma, AbbVie and Sunovion; is serving as an expert witness in litigation related to paraquat and Parkinson’s disease, received publishing royalties from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press.
